跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,857 条关于
“Lu-PSMA-617”
全部
3,857
临床试验
2,211
药物
1,035
机构
7
资讯
604
3年前
Radionuclide Therapy Shows Promise in Advanced Prostate Cancer Treatment
去年
Lutetium-177-PSMA-617 Shows Promise in Advanced Prostate Cancer Treatment
9个月前
Archeus Technologies Initiates First-in-Human Trial of ART-101 PSMA-Targeting Radioligand Therapy for Metastatic Prostate Cancer
去年
Telix's Illuccix Receives Expanded Approval in Australia and Canada for PSMA-Targeted Therapy Selection
去年
Actinium Pharmaceuticals Unveils ATNM-400: A Breakthrough Non-PSMA Targeted Radiotherapy for Prostate Cancer
2年前
UpFrontPSMA Trial: Lutetium-PSMA Plus Docetaxel Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer
3年前
FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
去年
Lutetium Lu 177 Vipivotide Tetraxetan Shows Promise in Prostate Cancer Treatment
去年
Lutetium-177 PSMA-617 Demonstrates Efficacy in Metastatic Castration-Resistant Prostate Cancer
5年前
Advancements in PSMA-Targeted Radionuclide Therapy for Metastatic Prostate Cancer
第 1 页,共 61 页
上一页
下一页